|
WASHINGTON (AP) - GlaxoSmithKline said Friday it obtained a temporary restraining order blocking the shipment and sales of a recently FDA-approved generic competitor to its Flonase nasal spray for allergies.
A federal judge in Baltimore granted the 10-day order late Thursday, GlaxoSmithKline spokeswoman Mary Anne Rhyne said.
The order applies to both Roxane Laboratories Inc.'s Fluticasone Propionate Nasal Spray, which the Food and Drug Administration approved Wednesday, and Par Pharmaceutical Companies Inc.'s own generic version of Flonase, which GlaxoSmithKline authorized. Pharmaceutical companies often license generic versions of their own drugs to undercut generic competitors just as they come onto the market with their own versions of a drug.
|